Efficacy and safety of therapeutic strategies for human brucellosis: A systematic review and network meta-analysis
PLOS Neglected Tropical Diseases · 2024
DOI: 10.1371/journal.pntd.0012010 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift PLOS Neglected Tropical Diseases, 2024. Verfasst von Sarah Nascimento Silva und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pesquisa Clínica e Políticas Públicas em Doenças Infecto-Parasitárias, Fundação Oswaldo Cruz, Belo Horizonte, Minas Gerais, Brazil. Hauptthemen laut MEDLINE: Brucellosis, Anti-Bacterial Agents, Doxycycline, Drug Therapy, Combination. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health - Brazil, National Counsel Technological and Scientific Developments – CNPq, Ministério da Saúde.
Abstract (Originalsprache)
Background
Human brucellosis is a neglected, re-emerging, and endemic zoonosis in many countries. The debilitating and disabling potential of the disease is a warning about its morbidity, generating socioeconomic impact. This review aims to update the current evidence on the efficacy and safety of therapeutic options for human brucellosis using the network meta-analysis (NMA). Methodology A systematic search was conducted in four different databases by independent reviewers to assess overall therapy failure, adverse events, and time to defervescence associated with different therapies. Randomized clinical trials (RCTs) evaluating any therapeutic drug intervention were selected, excluding non-original studies or studies related to localized forms of the disease or with less than 10 participants. Data were analyzed by frequentist statistics through NMA by random effects model. The risk of bias and certainty of evidence was assessed, this review was registered at PROSPERO.
Results
Thirty-one (31) RCTs involving 4167 patients were included. Three networks of evidence were identified to evaluate the outcomes of interest. Triple therapy with doxycycline + streptomycin + hydroxychloroquine for 42 days (RR: 0.08; CI 95% 0.01–0.76) had a lower failure risk than the doxycycline + streptomycin regimen. Doxycycline + rifampicin had a higher risk of failure than doxycycline + streptomycin (RR: 1.96; CI 95% 1.27–3.01). No significant difference was observed between the regimens when analyzing the incidence of adverse events and time to defervescence. In general, most studies had a high risk of bias, and the results had a very low certainty of evidence.
Conclusions
This review confirmed the superiority of drugs already indicated for treating human brucellosis, such as the combination of doxycycline and aminoglycosides. The association of hydroxychloroquine to the dual regimen was identified as a potential strategy to prevent overall therapy failure, which is subject to confirmation in future studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Pesquisa Clínica e Políticas Públicas em Doenças Infecto-Parasitárias, Fundação Oswaldo Cruz, Belo Horizonte, Minas Gerais, Brazil.
- Programa de Pós-Graduação em Reabilitação e Desempenho Funcional, Departamento de Fisioterapia, Universidade Federal dos Vales do Jequitinhonha e Mucuri, Diamantina Minas Gerais, Brazil.
- Programa de Pós-Graduação em Odontologia Universidade Federal dos Vales do Jequitinhonha e Mucuri, Diamantina Minas Gerais, Brazil.
- Programa de Pós-Graduação em Odontologia, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
- Programa de Pós-Graduação em Estomatopatologia da Universidade Estadual de Campinas, Campinas, São Paulo, Brazil.
- Pontifícia Universidade Católica do Paraná, Curitiba, Paraná, Brazil.
ORCID-Profile: Sarah Nascimento Silva, Felipe Francisco Tuon
Förderung
- Ministry of Health - Brazil
- National Counsel Technological and Scientific Developments – CNPq
- Ministério da Saúde
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
Zitieren
APA
Silva, S. N., Cota, G., Xavier, D. M., de Souza, G. M., Souza, M. R. F., Gonçalves, M. W. A., Tuon, F. F., & Galvão, E. L. (2024). Efficacy and safety of therapeutic strategies for human brucellosis: A systematic review and network meta-analysis. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0012010
Vancouver
Silva SN, Cota G, Xavier DM, de Souza GM, Souza MRF, Gonçalves MWA, et al. Efficacy and safety of therapeutic strategies for human brucellosis: A systematic review and network meta-analysis. PLOS Neglected Tropical Diseases. 2024. doi:10.1371/journal.pntd.0012010
BibTeX
@article{Silva2024,
author = {Silva, Sarah Nascimento and Cota, Gláucia and Xavier, Diego Mendes and de Souza, Glaciele Maria and Souza, Marina Rocha Fonseca and Gonçalves, Moisés Willian Aparecido and Tuon, Felipe Francisco and Galvão, Endi Lanza},
title = {Efficacy and safety of therapeutic strategies for human brucellosis: A systematic review and network meta-analysis},
journal = {PLOS Neglected Tropical Diseases},
year = {2024},
doi = {10.1371/journal.pntd.0012010}
}
EUVIMED